Physician profile
Robert Palusinski
NPI 1770750044
$1,569.38
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,410 · 2020: $42.27 · 2023: $94.58 · 2024: $22.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $697.37 | 2019 | |
| Amgen INC. | $259.20 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.08 | 2019-2020 | |
| Edwards Lifesciences Corporation | $94.58 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $86.07 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $76.33 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $62.55 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $53.16 | 2019 | |
| Sanofi-Aventis U.S. LLC | $34.47 | 2019 | |
| Abbott Laboratories | $23.30 | 2019-2020 | |
| Irhythm Technologies, INC. | $22.86 | 2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $16.16 | 2019 | |
| Portola Pharmaceuticals, LLC | $15.21 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Palusinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.